Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of deferasirox 500 mg dispersible tablets in healthy Thai adults under fasting conditions
TCTR20170222005Phase 4Not yet recruiting
- Sponsor
- Research and Development
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deferasirox, sponsored by Research and Development. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
deferasirox
Beyond the preview
Go deeper on TCTR20170222005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170222005.